Original text: http://sci-hub.io/10.2105/AJPH.2017.303982 Most of these were speaking fees. In addition, 'payments' includes any transfer of value. If a pharma company rep buys a doctor a coffee, they're classed as paying them. Same thing if they sponsor a lunch at a conference. That's where the 1 in 12 figure comes from. Most of the money is from speakers fees, which is limited to a very small subsection of doctors.